We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Transduction of ferret airway epithelia using a pre-treatment and lentiviral gene vector.
- Authors
Cmielewski, Patricia; Farrow, Nigel; Donnelley, Martin; McIntyre, Chantelle; Penny-Dimri, Jahan; Kuchel, Tim; Parsons, David
- Abstract
Background The safety and efficiency of gene therapies for cystic fibrosis (CF) need to be assessed in preclinical models. Using the normal ferret, this study sought to determine whether ferret airway epithelia could be transduced with a lysophosphatidylcholine (LPC) pre-treatment followed by a VSV-G pseudotyped HIV-1 based lentiviral (LV) vector, in preparation for future studies in CF ferrets. Methods Six normal ferrets (7 -8 weeks old) were treated with a 150 μL LPC pre-treatment, followed one hour later by a 500 μL LV vector dose containing the LacZ transgene. LacZ gene expression in the conducting airways and lung was assessed by X-gal staining after 7 days. The presence of transduction in the lung, as well as off-target transduction in the liver, spleen and gonads, were assessed by qPCR. The levels of LV vector p24 protein bio-distribution in blood sera were assessed by ELISA at 0, 1, 3, 5 and 7days. Results The dosing protocol was well tolerated. LacZ gene expression was observed en face in the trachea of all animals. Histology showed that ciliated and basal cells were transduced in the trachea, with rare LacZ transduced single cells noted in lung. p24 levels was not detectable in the sera of 5 of the 6 animals. The LacZ gene was not detected in the lung tissue and no offtarget transduction was detected by qPCR. Conclusions This study shows that ferret airway epithelia are transducible using our unique two-step pretreatment and LV vector dosing protocol. We have identified a number of unusual anatomical factors that are likely to influence the level of transduction that can be achieved in ferret airways. The ability to transduce ferret airway epithelium is a promising step towards therapeutic LV-CFTR testing in a CF ferret model.
- Subjects
CYSTIC fibrosis treatment; FERRET; LYSOPHOSPHATIDYLCHOLINE acyltransferase; GENE therapy; LENTIVIRUS diseases; DISEASES
- Publication
BMC Pulmonary Medicine, 2014, Vol 14, Issue 1, p1
- ISSN
1471-2466
- Publication type
Article
- DOI
10.1186/1471-2466-14-183